Companies / BOC Sciences / Camidanlumab
BOC Sciences

Camidanlumab | BOC Sciences

Camidanlumab is a monoclonal antibody targeting CD25, which is expressed on activated T cells. Camidanlumab can be used in the synthesis of ADC Camidanlumab tesirine, which is investigated for the treatment of lymphoma and leukemia.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.